Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP alone versus PRP + SVF for androgenetic alopecia
IRCT20210414050963N1Phase 3Completed
- Sponsor
- Skin and Stem Cell Research Center
- Start
- Aug 2021
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of platelet-rich plasma and autologous adipose stromal vascular fraction in androgenetic alopecia (AGA) (2 arms), sponsored by Skin and Stem Cell Research Center. Primary endpoints: Alopecia severity, Hair in telogen phase and 3 more. Started Aug 2021; status: completed.
02
Drugs
platelet-rich plasmaautologous adipose stromal vascular fraction
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on IRCT20210414050963N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210414050963N1.